Date post: | 01-Jan-2016 |
Category: |
Documents |
Upload: | keely-holman |
View: | 20 times |
Download: | 2 times |
Screening for Diabetic Screening for Diabetic Retinopathy in EuropeRetinopathy in Europe
Progress since 2005Progress since 2005
Report from National Report from National Representatives MeetingRepresentatives Meeting
Simon HardingSimon Harding
Amsterdam 30th May 2008
The St. Vincent DeclarationThe St. Vincent Declaration
Implement effective measures for the prevention of Implement effective measures for the prevention of costly complicationscostly complications
Reduce new blindness due to diabetes by one third or more
General Goal for people with diabetesGeneral Goal for people with diabetesSustained improvement in health experience and life
approaching normal expectation in quality and quantity
Liverpool 2005Liverpool 2005
Liverpool Town Hall 17-18th November 2005
The Liverpool DeclarationThe Liverpool Declaration
European countries should:
Reduce the risk of visual impairment due to diabetic retinopathy by 2010 through:
• systematic programmes of screening reaching at least 80% of the population with diabetes
• using trained professionals and personnel
• universal access to laser therapy
Three componentsThree components
Organisation
Personnel
Equipment, tests and treatment
www.drscreening2005.org.uk
www.drscreening.eu
ImplementationImplementation
• Establish joint meetingsEstablish joint meetings• Set up training programmesSet up training programmes• Move from local to regional to national Move from local to regional to national
implementationimplementation• Establish policy including defined goalsEstablish policy including defined goals• Set national guidelinesSet national guidelines• Agree timeframeAgree timeframe• Don’t give up!Don’t give up!
30 May 2008Amsterdam
Conference objectivesConference objectives
To review Liverpool Declaration targets and report on progress To describe obstacles to implementation
To develop further guidance
To engage stakeholders
DelegatesDelegates
46 European countries invited• diabetologist, ophthalmologist
26 European countries represented67 delegates
Groups of NationsGroups of Nations
Group 1Group 1
Czech Republic, Hungary, Poland, Serbia, TurkeyCzech Republic, Hungary, Poland, Serbia, Turkey
Group 2Group 2
Denmark, England, Finland, Iceland, Scotland, Denmark, England, Finland, Iceland, Scotland, Sweden, Wales Sweden, Wales
Group 3Group 3
Belgium, France, Greece, Ireland, Italy, Luxembourg, Belgium, France, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, (Germany, Israel, Spain)Netherlands, Portugal, (Germany, Israel, Spain)
Group 4Group 4
Albania, Belarus, Bulgaria, Georgia, LithuaniaAlbania, Belarus, Bulgaria, Georgia, Lithuania
30 May 2008Amsterdam
Key messagesKey messages
Significant progress made since 2005Significant progress made since 2005
Nearly all countries have taken a step forward:Nearly all countries have taken a step forward:• established systematic screeningestablished systematic screening• developing local to regional to nationaldeveloping local to regional to national• patchy progress:patchy progress:
– development of national guidelinesdevelopment of national guidelines– training programmes being startedtraining programmes being started– regional/national implementation groupsregional/national implementation groups
This has been led by a small/medium groups of This has been led by a small/medium groups of champions in each countrychampions in each country
30 May 2008Amsterdam
~1/3 report likely to achieve 2010 targets, others part~1/3 report likely to achieve 2010 targets, others part
Key messagesKey messages
Wide variation in prevalenceWide variation in prevalence• 3-5% majority3-5% majority• 7.9% Belgium, 6.9% Portugal, 7% Georgia 7.9% Belgium, 6.9% Portugal, 7% Georgia • 9.0% Finland high frequency of type 19.0% Finland high frequency of type 1• >10% Greece>10% Greece• PDR 23.5% in Czech RepublicPDR 23.5% in Czech Republic• <2% in Belarus, Bulgaria, Lithuania; <1% in <2% in Belarus, Bulgaria, Lithuania; <1% in
AlbaniaAlbania
Expected big increaseExpected big increase
30 May 2008Amsterdam
Key messagesKey messages
Access to laser still poor in a few countriesAccess to laser still poor in a few countries
Problems with continued secure funding in long Problems with continued secure funding in long established programmes (Iceland)established programmes (Iceland)
Some bizzare perverse incentivesSome bizzare perverse incentives• avastin/TA being given even when laser is avastin/TA being given even when laser is
availableavailable
30 May 2008Amsterdam
Issues identifiedIssues identified
Public awarenessPublic awareness
Patient compliancePatient compliance
Lack of funding for equipment, training, educationLack of funding for equipment, training, education
Collaboration between ophthalmologists and Collaboration between ophthalmologists and diabetologistsdiabetologists
Lack of engagement of private providers of eye careLack of engagement of private providers of eye care
systematic process, competency, registers, datasystematic process, competency, registers, data
Political instabilityPolitical instability
30 May 2008Amsterdam
Recommendations Group 1Recommendations Group 1
Raise awareness of diabetes and retinopathy •particularly primary care providers•also patients and public
Adequate funding for lasers and fundus cameras•(personnel not such an issue)
Establish call recall systems as the key method of the development of diabetes registers•can only be achieved by moving from local to regional to national
Recommendations Group 2Recommendations Group 2
For established screening programmes:
Quality improvement plan against explicit measureable standards across all components of screening and management•focus on management of screen positive cases
Comprehensive list of people with diabetes with regular maintenance
Integrate eye screening results with general diabetes care
Recommendations Group 3Recommendations Group 3
Develop registers of people with diabetes•consider alternative sources of data: pharmacy, pharmaceutical data, insurance data•unique identifiers•local – regional – national
Engage private eye care providers•involve health insurers in establishing systematic screening•guidelines for all professional groups should require fundus imaging at the agreed frequency•data transmission to a linked independently funded database•ensure no requirement to refer screen +ve patients
Recommendations Group 4Recommendations Group 4
Raise awareness of diabetes and retinopathy •particularly with patient groups
Adequate funding for lasers and fundus cameras•particularly for training programmes
Governments should fund the development and adoption of guidelines•funding can be better utilised if the frequency of screening can be reduced
Mobile screening is most relevant to rural areas
How can we make further progress?How can we make further progress?
European Organisations Representatives: Dr. Christoph Steffen, European Commission, Information Society & Media DGDr. Wim Wientjens, Vice President, International Diabetes FoundationDr. Ivo Kocur, Prevention of Blindness and Deafness (PBD), World Health OrganisationDr. Karl-Jurgen Schmitt, Chairman, Structural Funds Task Force, COCIR
Where next?Where next?
draft conference report circulated to national representatives final report circulated to key European organisationswebsite will post abstracts and presentations
next meeting in 2011 to review 2010 targets
Organising CommitteeOrganising Committee
Organising CommitteeDeborah Broadbent, Simon Harding, Ken Swa, Bettine Polak, Annette Moll
ModeratorsDeborah Broadbent, Eva Kohner, Ken Swa, Simon Harding
Conference SecretariatLindy Gee, Jitta Reddingius, Ingrid van Vegde
Thank you